Encompass Health Corp
EHC105.390USD
+5.800+5.83%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
10.60BValor de mercado
18.71P/L TTM
Mais detalhes de Encompass Health Corp Empresa
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
Informações de Encompass Health Corp
Código da empresaEHC
Nome da EmpresaEncompass Health Corp
Data de listagemSep 24, 1986
CEOTarr (Mark J)
Número de funcionários23564
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 24
Endereço9001 Liberty Pkwy
CidadeBIRMINGHAM
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal35242-7509
Telefone12059677116
Sitehttps://www.encompasshealth.com/
Código da empresaEHC
Data de listagemSep 24, 1986
CEOTarr (Mark J)
Executivos da empresa Encompass Health Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3667.00%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.84K
+87.00%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.26K
+40.00%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-1020.00%
Mr. Gregory D. (Greg) Carmichael
Mr. Gregory D. (Greg) Carmichael
Independent Director
Independent Director
18.66K
+28.00%
Mr. Christopher R. (Chris) Reidy
Mr. Christopher R. (Chris) Reidy
Independent Director
Independent Director
15.45K
+365.00%
Mr. Terrance Williams
Mr. Terrance Williams
Independent Director
Independent Director
15.17K
+28.00%
Dr. Elissa Joy Charbonneau
Dr. Elissa Joy Charbonneau
Chief Medical Officer
Chief Medical Officer
11.96K
-4279.00%
Mr. Kevin J. O'Connor
Mr. Kevin J. O'Connor
Independent Director
Independent Director
9.91K
+17.00%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Mark J. Tarr
Mr. Mark J. Tarr
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
527.07K
--
Mr. Edmund M. (Ed) Fay
Mr. Edmund M. (Ed) Fay
Senior Vice President, Treasurer
Senior Vice President, Treasurer
95.27K
-3667.00%
Ms. Leslye G Katz
Ms. Leslye G Katz
Independent Director
Independent Director
47.84K
+87.00%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Independent Director
Independent Director
21.26K
+40.00%
Mr. Patrick W. (Pat) Tuer
Mr. Patrick W. (Pat) Tuer
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
18.85K
-1020.00%
Mr. Gregory D. (Greg) Carmichael
Mr. Gregory D. (Greg) Carmichael
Independent Director
Independent Director
18.66K
+28.00%
Detalhamento da receita
Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
Por EmpresaUSD
Nome
Receita
Proporção
Medicare
946.10M
64.03%
Medicare Advantage
245.70M
16.63%
Managed Care
164.60M
11.14%
Medicaid
50.00M
3.38%
Other Income Source
47.90M
3.24%
Outro
23.20M
1.57%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Medicare
946.10M
64.03%
Medicare Advantage
245.70M
16.63%
Managed Care
164.60M
11.14%
Medicaid
50.00M
3.38%
Other Income Source
47.90M
3.24%
Outro
23.20M
1.57%
Distribuição de ações
Atualizado em: dom, 1 de fev
Atualizado em: dom, 1 de fev
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Outro
70.27%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
10.04%
BlackRock Institutional Trust Company, N.A.
8.43%
Invesco Advisers, Inc.
4.45%
T. Rowe Price Associates, Inc.
3.74%
State Street Investment Management (US)
3.06%
Outro
70.27%
Tipos de investidores
Investidores
Proporção
Investment Advisor
49.26%
Investment Advisor/Hedge Fund
34.60%
Hedge Fund
6.40%
Bank and Trust
2.32%
Pension Fund
1.91%
Research Firm
1.80%
Individual Investor
1.24%
Sovereign Wealth Fund
1.24%
Insurance Company
0.13%
Outro
1.10%
Participação acionária institucional
Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
1060
97.92M
98.83%
-7.16K
2025Q3
1072
97.93M
99.39%
+709.65K
2025Q2
1033
97.25M
101.81%
-1.92M
2025Q1
979
99.67M
102.60%
-3.66M
2024Q4
945
99.00M
102.85%
-881.71K
2024Q3
884
99.36M
106.17%
-310.63K
2024Q2
889
99.51M
109.15%
-995.73K
2024Q1
858
100.71M
112.68%
-12.13M
2023Q4
852
101.16M
110.27%
+2.80M
2023Q3
865
97.95M
111.77%
+322.90K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
10.22M
10.15%
-140.47K
-1.36%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
8.48M
8.43%
-4.83K
-0.06%
Sep 30, 2025
Invesco Advisers, Inc.
4.48M
4.45%
-276.20K
-5.81%
Sep 30, 2025
T. Rowe Price Associates, Inc.
3.77M
3.74%
+2.44M
+184.81%
Sep 30, 2025
State Street Investment Management (US)
3.08M
3.06%
-24.31K
-0.78%
Sep 30, 2025
Wellington Management Company, LLP
2.78M
2.76%
-744.16K
-21.11%
Sep 30, 2025
AllianceBernstein L.P.
2.52M
2.5%
+476.56K
+23.37%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
2.14M
2.13%
-34.67K
-1.59%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
2.06M
2.05%
+238.21K
+13.06%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.81M
1.8%
+34.70K
+1.96%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
PGIM Jennison Focused Mid-Cap ETF
3.17%
Inspire Growth ETF
2.88%
Opus Small Cap Value ETF
2.23%
State Street SPDR S&P Health Care Services ETF
1.86%
iShares U.S. Healthcare Providers ETF
1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
1.74%
Bahl & Gaynor Dividend ETF
1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
JPMorgan Active Small Cap Value ETF
1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
1.07%
Ver Mais
PGIM Jennison Focused Mid-Cap ETF
Proporção3.17%
Inspire Growth ETF
Proporção2.88%
Opus Small Cap Value ETF
Proporção2.23%
State Street SPDR S&P Health Care Services ETF
Proporção1.86%
iShares U.S. Healthcare Providers ETF
Proporção1.8%
ALPS O'Shares US Small-Cap Quality Dividend ETF
Proporção1.74%
Bahl & Gaynor Dividend ETF
Proporção1.5%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção1.18%
JPMorgan Active Small Cap Value ETF
Proporção1.09%
iShares MSCI USA Small-Cap Min Vol Factor ETF
Proporção1.07%
Dividendo
Um total de
334.60M
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Oct 23, 2025
EHC.NB Final Cash Dividend of gross USD 0.19 paid on Jan 15, 2026 going ex on Jan 02, 2026
Jan 02, 2026
Jan 15, 2026
Jan 02, 2026
Jul 24, 2025
EHC.NB Interim Cash Dividend of gross USD 0.19 paid on Oct 15, 2025 going ex on Oct 01, 2025
Oct 01, 2025
Oct 15, 2025
Oct 01, 2025
May 01, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 15, 2025 going ex on Jul 01, 2025
Jul 01, 2025
Jul 15, 2025
Jul 01, 2025
Feb 20, 2025
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 15, 2025 going ex on Apr 01, 2025
Apr 01, 2025
Apr 15, 2025
Apr 01, 2025
Oct 17, 2024
EHC.NB Final Cash Dividend of gross USD 0.17 paid on Jan 15, 2025 going ex on Jan 02, 2025
Jan 02, 2025
Jan 15, 2025
Jan 02, 2025
Jul 24, 2024
EHC.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 15, 2024 going ex on Oct 01, 2024
Oct 01, 2024
Oct 15, 2024
Oct 01, 2024
May 02, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Jul 15, 2024 going ex on Jul 01, 2024
Jul 01, 2024
Jul 15, 2024
Jul 01, 2024
Feb 28, 2024
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Apr 15, 2024 going ex on Mar 28, 2024
Apr 01, 2024
Apr 15, 2024
Mar 28, 2024
Oct 19, 2023
EHC.NB Final Cash Dividend of gross USD 0.15 paid on Jan 16, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 16, 2024
Dec 29, 2023
Jul 20, 2023
EHC.NB Interim Cash Dividend of gross USD 0.15 paid on Oct 16, 2023 going ex on Sep 29, 2023
Oct 02, 2023
Oct 16, 2023
Sep 29, 2023
Ver Mais
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
